NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 7, Issue 6, Pages e2269-e2269
Publisher
Springer Nature
Online
2016-06-24
DOI
10.1038/cddis.2016.175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway
- (2015) Yesol Bak et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of a mitochondrial defect gene signature revealsNUPR1as a key regulator of liver cancer progression
- (2015) Young-Kyoung Lee et al. HEPATOLOGY
- The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
- (2015) Valentina Tesori et al. Scientific Reports
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon
- (2015) Melchiorre Cervello et al. Oncotarget
- Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer
- (2014) T. W. Owens et al. CANCER RESEARCH
- IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation
- (2014) Maria Noé Garcia et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype
- (2013) So Mee Kwon et al. CARCINOGENESIS
- Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells
- (2013) Melchiorre Cervello et al. PLoS One
- Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
- (2013) Johanna Dzieran et al. PLoS One
- Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells
- (2013) Zhi-Qiang Wang et al. PLoS One
- Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
- (2012) Seiki Miura et al. BMC CANCER
- Sorafenib increases endoplasmic reticulum (ER) stress in concert with vorinostat
- (2012) Teruo Inamoto et al. CANCER BIOLOGY & THERAPY
- Molecular mechanisms of sorafenib action in liver cancer cells
- (2012) Melchiorre Cervello et al. CELL CYCLE
- Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance
- (2012) Andrew J. Vincent et al. FEBS LETTERS
- Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis
- (2012) Tewfik Hamidi et al. JOURNAL OF CLINICAL INVESTIGATION
- Induction of Endoplasmic Reticulum Stress by Sorafenib and Activation of NF- B by Lestaurtinib as a Novel Resistance Mechanism in Hodgkin Lymphoma Cell Lines
- (2012) M. S. Holz et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib-Mediated Targeting of the AAA+ ATPase p97/VCP Leads to Disruption of the Secretory Pathway, Endoplasmic Reticulum Stress, and Hepatocellular Cancer Cell Death
- (2012) P. Yi et al. MOLECULAR CANCER THERAPEUTICS
- Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma
- (2012) Wei Li et al. TUMOR BIOLOGY
- Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
- (2011) Ying-Hong Shi et al. Autophagy
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- Identification of the common regulators for hepatocellular carcinoma induced by hepatitis B virus X antigen in a mouse model
- (2011) Jeng-Wei Lu et al. CARCINOGENESIS
- Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells
- (2011) Luigi Fiume et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- p8 Expression controls pancreatic cancer cell migration, invasion, adhesion, and tumorigenesis
- (2011) Maria Jose Sandi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
- (2011) Wei-Tien Tai et al. JOURNAL OF HEPATOLOGY
- Stress Proteins and Pancreatic Cancer Metastasis
- (2011) Carla E. Cano et al. TheScientificWorldJOURNAL
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
- (2010) S. Roessler et al. CANCER RESEARCH
- Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells
- (2010) Antonella Cusimano et al. CELL CYCLE
- Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis
- (2010) Alexander Arlt et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Nupr1: The Swiss-knife of cancer
- (2010) Carla E. Cano et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
- (2009) K. J. Archer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Unknown
- (2009) Valeria Mas et al. MOLECULAR MEDICINE
- Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma
- (2009) Zhen Ding et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More